glutathione mutations in sclc patients Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy NRF2 supports non-small cell lung
NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Increased antioxidative defense and reduced advanced glycation end product formation by metabolic adaptation in non small cell lung cancer patients Nature Communications Small cells big issues: biological implications and preclinical advancements in small cell lung cancer Molecular Cancer Springer Nature Link
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




